LFG
PRCT icon

Larson Financial Group’s Procept Biorobotics PRCT Stock Holding History

Larson Financial Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339 Sell
15
-30
-67% -$751 ﹤0.01% 3556
2026
Q1 		$1.13K Buy
45
+30
+200% +$845 ﹤0.01% 3119
2025
Q4 		$472 Sell
15
-176
-92% -$5.84K ﹤0.01% 3137
2025
Q3 		$6.82K Buy
191
+176
+1,173% +$8.04K ﹤0.01% 2221
2025
Q2 		$864 Hold
15
– – ﹤0.01% 2688
2025
Q1 		$874 Hold
15
– – ﹤0.01% 2424
2024
Q4 		$1.21K Hold
15
– – ﹤0.01% 1986
2024
Q3 		$1.2K Hold
15
– – ﹤0.01% 1951
2024
Q2 		$916 Buy
+15
New +$892 ﹤0.01% 1727

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Larson Financial Group's PRCT Position: Q2 2026 in Review

Larson Financial Group reduced its Procept Biorobotics (PRCT) stake by 67% in Q2 2026, selling an estimated $751 and leaving 15 shares worth $339. The position accounts for ﹤0.01% of the portfolio, ranked #3556.

Larson Financial Group first reported a position in PRCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.82K in Q3 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Larson Financial Group held 15 shares of Procept Biorobotics worth $339 as of Q2 2026.
  • Larson Financial Group sold 30 Procept Biorobotics shares in Q2 2026, an estimated $751.
  • Procept Biorobotics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3556 holding.
  • Larson Financial Group first reported a position in Procept Biorobotics in Q2 2024 and has held it in 9 quarters since.
  • Larson Financial Group's Procept Biorobotics position peaked at $6.82K in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.